Cutler Group LP Lantheus Holdings, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	BUY	$60.27 - $90.75 $60,270 - $90,750	1,000 New	1,000 $1,000
Q4 2022 Feb 07, 2023	BUY	$48.76 - $77.67 $19,504 - $31,068	400 Added 5.26%	8,000 $14,000
Q3 2022 Oct 25, 2022	BUY	$61.42 - $86.29 $466,792 - $655,804	7,600 New	7,600 $14,000
Q1 2018 May 11, 2018	SELL	$14.85 - $24.3 $7,425 - $12,150	-500 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$17.4 - $23.4 $17,400 - $23,400	-1,000 Reduced 66.67%	500 $0
Q3 2017 Oct 17, 2017	BUY	$15.5 - $19.15 $23,250 - $28,724	1,500	1,500 $0

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.